• Skip to primary navigation
  • Skip to main content
  • Skip to footer

Center for RNA Biomedicine

Ann Arbor, MI

MembershipGive online

MENUMENU
  • Home
  • About
    • About RNA
    • Mission
    • Become a Member
    • History
    • Financial Support
    • Diversity, Equity & Inclusion
  • Research
    • Core Facilities
      • Bru-Seq Lab
      • Single Molecule Analysis in RT
    • Scientific Articles
    • Scientific Articles Highlights
    • Pilot Grants (2017–18)
  • People
    • U-M Faculty Members
    • RNA Faculty Scholars
    • Faculty Testimonials
    • Featured Researchers
    • Leadership and Staff
      • Directors
      • Executive Committee
      • Strategic Advisory Board
      • Student & PostDoc Council
      • Staff
  • Resources
    • Grant Sprints
    • Grant Proposal Support
    • Recruitment Opportunities
    • Publication Support
    • RNA Skills
      • RNA Skill Share
      • Technique Demo Videos
      • RNA Research Scholar Exchange Supplemental Fund
    • U-M RNA Resources
      • U-M Research Cores
      • RNA courses at U-M
      • U-M Depts & Centers
    • Non U-M RNA Partners
  • Events
    • Calendar
    • Symposia
      • 2023 Symposium
      • 2022 Symposium
      • 2021 Symposium
      • 2020 Symposium
      • 2019 Symposium
      • 2018 Symposium
      • 2017 Symposium
      • 2016 Inaugural Symposium
    • RNA Innovation Seminars
      • 2022-2023 Seminars
      • 2021-2022 Seminars
      • 2020-2021 Seminars
      • 2019-2020 Seminars
      • 2018-2019 RNA Seminars
      • 2017-2018 RNA Seminars
      • 2016-2017 RNA Seminars
      • 2015-2016 RNA Seminars
    • RNA Collaborative Seminar Series
  • News
    • In the Media
  • Our Publications
    • Weekly News
      • Weekly News Archive
    • Magazine and Report
      • RNA Translated 2021, “RNA Therapeutics”
      • RNA Translated 2020, “The Year of the RNA Virus”
    • Center’s Brochure
    • Join our Mailing List
  • Giving
  • Contact

Repurposing Prostate Cancer Drug for COVID-19

01/19/2021

In our September 2020 issue of RNA Translated, 2020 the year of the RNA virus, we presented how University of Michigan (U-M) Center for RNA Biomedicine’s scientists pivoted their research to address the COVID-19 pandemic. One of them is Dr. Chinnaiyan and his team of prostate cancer researchers who focused on two proteins that are involved in giving access to the virus into a host cell. The production of these two proteins is regulated by male hormones. With J. Sexton from the U-M Center for Drug Repurposing, the collaborators looked at repurposing well-known drugs used in prostate cancer to block a receptor for male hormone, and prevent the coronavirus from entering a host cell.

“We hope that these findings may partly explain why males have higher hospitalization and mortality rates than females, and also suggest that transcriptional inhibition of key host factors may have potential in preventing or treating COVID-19. A number of clinical trials in COVID-19 patients have been initiated with drugs that were previously used to treat prostate cancer,” says Dr. Chinnaiyan.

The results from the current study are published in the January 5, 2021, Proceedings of the National Academy of Sciences.


Referenced article:

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
Yuanyuan Qiao, Xiao-Ming Wang, Rahul Mannan, Sethuramasundaram Pitchiaya, Yuping Zhang, Jesse W. Wotring, Lanbo Xiao, Dan R. Robinson, Yi-Mi Wu, Jean Ching-Yi Tien, Xuhong Cao, Stephanie A. Simko, Ingrid J. Apel, Pushpinder Bawa, Steven Kregel, Sathiya P. Narayanan, Gregory Raskind, Stephanie J. Ellison, Abhijit Parolia, Sylvia Zelenka-Wang, Lisa McMurry, Fengyun Su, Rui Wang, Yunhui Cheng, Andrew D. Delekta, Zejie Mei, Carla D. Pretto, Shaomeng Wang, Rohit Mehra, Jonathan Z. Sexton, and Arul M. Chinnaiyan, PNAS January 5, 2021 118 (1) e2021450118; first published December 11, 2020; https://doi.org/10.1073/pnas.2021450118

Filed Under: News, Publication Highlights

Footer

Copyright © 2023 University of Michigan Board of Regents